MODIV INDUSTRIAL INC (MDV) Fundamental Analysis & Valuation

NYSE:MDV • US60784B1017

14.92 USD
-0.07 (-0.47%)
Last: Mar 11, 2026, 12:49 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This MDV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MDV. MDV was compared to 123 industry peers in the Diversified REITs industry. MDV has only an average score on both its financial health and profitability. While showing a medium growth rate, MDV is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. MDV Profitability Analysis

1.1 Basic Checks

  • MDV had positive earnings in the past year.
  • In the past year MDV had a positive cash flow from operations.
  • In the past 5 years MDV reported 4 times negative net income.
  • MDV had a positive operating cash flow in each of the past 5 years.
MDV Yearly Net Income VS EBIT VS OCF VS FCFMDV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

  • MDV's Return On Assets of -0.54% is on the low side compared to the rest of the industry. MDV is outperformed by 65.04% of its industry peers.
  • With a Return On Equity value of -1.63%, MDV is not doing good in the industry: 65.04% of the companies in the same industry are doing better.
  • MDV has a Return On Invested Capital of 3.21%. This is in the better half of the industry: MDV outperforms 61.79% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for MDV is in line with the industry average of 3.14%.
  • The 3 year average ROIC (2.12%) for MDV is below the current ROIC(3.21%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.54%
ROE -1.63%
ROIC 3.21%
ROA(3y)-1.01%
ROA(5y)-3.09%
ROE(3y)-3.42%
ROE(5y)-9.27%
ROIC(3y)2.12%
ROIC(5y)1.53%
MDV Yearly ROA, ROE, ROICMDV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

  • With an excellent Operating Margin value of 42.50%, MDV belongs to the best of the industry, outperforming 88.62% of the companies in the same industry.
  • MDV's Operating Margin has improved in the last couple of years.
  • MDV's Gross Margin of 92.56% is amongst the best of the industry. MDV outperforms 94.31% of its industry peers.
  • In the last couple of years the Gross Margin of MDV has grown nicely.
Industry RankSector Rank
OM 42.5%
PM (TTM) N/A
GM 92.56%
OM growth 3Y67.86%
OM growth 5Y18.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.08%
GM growth 5Y2.86%
MDV Yearly Profit, Operating, Gross MarginsMDV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. MDV Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MDV is destroying value.
  • MDV has more shares outstanding than it did 1 year ago.
  • MDV has more shares outstanding than it did 5 years ago.
  • MDV has a worse debt/assets ratio than last year.
MDV Yearly Shares OutstandingMDV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
MDV Yearly Total Debt VS Total AssetsMDV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

  • Based on the Altman-Z score of 0.10, we must say that MDV is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 0.10, MDV is not doing good in the industry: 70.73% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of MDV is 17.98, which is on the high side as it means it would take MDV, 17.98 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of MDV (17.98) is better than 78.86% of its industry peers.
  • MDV has a Debt/Equity ratio of 1.70. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.70, MDV is doing worse than 65.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF 17.98
Altman-Z 0.1
ROIC/WACC0.5
WACC6.36%
MDV Yearly LT Debt VS Equity VS FCFMDV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

  • MDV has a Current Ratio of 4.25. This indicates that MDV is financially healthy and has no problem in meeting its short term obligations.
  • MDV has a better Current ratio (4.25) than 97.56% of its industry peers.
  • MDV has a Quick Ratio of 4.25. This indicates that MDV is financially healthy and has no problem in meeting its short term obligations.
  • MDV has a Quick ratio of 4.25. This is amongst the best in the industry. MDV outperforms 97.56% of its industry peers.
Industry RankSector Rank
Current Ratio 4.25
Quick Ratio 4.25
MDV Yearly Current Assets VS Current LiabilitesMDV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. MDV Growth Analysis

3.1 Past

  • MDV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 157.14%, which is quite impressive.
  • The Revenue has decreased by -0.59% in the past year.
  • MDV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.76% yearly.
EPS 1Y (TTM)157.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-0.59%
Revenue growth 3Y7.26%
Revenue growth 5Y13.76%
Sales Q2Q%0.27%

3.2 Future

  • MDV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.95% yearly.
  • The Revenue is expected to grow by 1.05% on average over the next years.
EPS Next Y-174.07%
EPS Next 2Y-22.81%
EPS Next 3Y22.95%
EPS Next 5YN/A
Revenue Next Year0.59%
Revenue Next 2Y0.65%
Revenue Next 3Y2.54%
Revenue Next 5Y1.05%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MDV Yearly Revenue VS EstimatesMDV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M 50M
MDV Yearly EPS VS EstimatesMDV Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. MDV Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 93.25, the valuation of MDV can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of MDV is on the same level as its industry peers.
  • MDV's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.25.
  • A Price/Forward Earnings ratio of 100.15 indicates a quite expensive valuation of MDV.
  • MDV's Price/Forward Earnings ratio is in line with the industry average.
  • MDV's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.39.
Industry RankSector Rank
PE 93.25
Fwd PE 100.15
MDV Price Earnings VS Forward Price EarningsMDV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • 75.61% of the companies in the same industry are more expensive than MDV, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, MDV is valued cheaply inside the industry as 88.62% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 9.85
EV/EBITDA 11.69
MDV Per share dataMDV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • MDV's earnings are expected to grow with 22.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-22.81%
EPS Next 3Y22.95%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. MDV Dividend Analysis

5.1 Amount

  • MDV has a Yearly Dividend Yield of 7.97%, which is a nice return.
  • MDV's Dividend Yield is rather good when compared to the industry average which is at 7.59. MDV pays more dividend than 81.30% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, MDV pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.97%

5.2 History

  • MDV has been paying a dividend for over 5 years, so it has already some track record.
  • MDV has decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
MDV Yearly Dividends per shareMDV Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • MDV has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-551.99%
EPS Next 2Y-22.81%
EPS Next 3Y22.95%
MDV Yearly Income VS Free CF VS DividendMDV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

More info and screens

Find the best dividend stocksShow peers with best dividend

MDV Fundamentals: All Metrics, Ratios and Statistics

MODIV INDUSTRIAL INC

NYSE:MDV (3/11/2026, 12:49:31 PM)

14.92

-0.07 (-0.47%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)03-10
Earnings (Next)N/A
Inst Owners24.02%
Inst Owner Change3.13%
Ins Owners1.97%
Ins Owner Change1.47%
Market Cap153.23M
Revenue(TTM)47.04M
Net Income(TTM)-2.68M
Analysts82
Price Target18.11 (21.38%)
Short Float %2.55%
Short Ratio5.86
Dividend
Industry RankSector Rank
Dividend Yield 7.97%
Yearly Dividend1.6
Dividend Growth(5Y)N/A
DP-551.99%
Div Incr Years0
Div Non Decr Years2
Ex-Date03-31
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)65.02%
Min EPS beat(2)-100%
Max EPS beat(2)230.03%
EPS beat(4)3
Avg EPS beat(4)104.41%
Min EPS beat(4)-100%
Max EPS beat(4)230.03%
EPS beat(8)5
Avg EPS beat(8)-93.26%
EPS beat(12)7
Avg EPS beat(12)26.74%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.46%
Min Revenue beat(2)-1.65%
Max Revenue beat(2)-1.28%
Revenue beat(4)1
Avg Revenue beat(4)-0.4%
Min Revenue beat(4)-1.65%
Max Revenue beat(4)1.93%
Revenue beat(8)2
Avg Revenue beat(8)-1.17%
Revenue beat(12)5
Avg Revenue beat(12)3.64%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.28%
PT rev (3m)0.95%
EPS NQ rev (1m)-13.28%
EPS NQ rev (3m)-2.63%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 93.25
Fwd PE 100.15
P/S 3.26
P/FCF 9.85
P/OCF 9.5
P/B 0.93
P/tB 0.94
EV/EBITDA 11.69
EPS(TTM)0.16
EY1.07%
EPS(NY)0.15
Fwd EY1%
FCF(TTM)1.52
FCFY10.16%
OCF(TTM)1.57
OCFY10.52%
SpS4.58
BVpS16.05
TBVpS15.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number7.6
Profitability
Industry RankSector Rank
ROA -0.54%
ROE -1.63%
ROCE 4.06%
ROIC 3.21%
ROICexc 3.27%
ROICexgc 3.28%
OM 42.5%
PM (TTM) N/A
GM 92.56%
FCFM 33.08%
ROA(3y)-1.01%
ROA(5y)-3.09%
ROE(3y)-3.42%
ROE(5y)-9.27%
ROIC(3y)2.12%
ROIC(5y)1.53%
ROICexc(3y)2.16%
ROICexc(5y)1.58%
ROICexgc(3y)2.18%
ROICexgc(5y)1.6%
ROCE(3y)2.69%
ROCE(5y)1.95%
ROICexgc growth 3Y59.93%
ROICexgc growth 5Y30.52%
ROICexc growth 3Y62.55%
ROICexc growth 5Y34.05%
OM growth 3Y67.86%
OM growth 5Y18.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.08%
GM growth 5Y2.86%
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF 17.98
Debt/EBITDA 7.69
Cap/Depr 3.44%
Cap/Sales 1.2%
Interest Coverage 1.51
Cash Conversion 44.32%
Profit Quality N/A
Current Ratio 4.25
Quick Ratio 4.25
Altman-Z 0.1
F-Score4
WACC6.36%
ROIC/WACC0.5
Cap/Depr(3y)581.06%
Cap/Depr(5y)371.93%
Cap/Sales(3y)189.95%
Cap/Sales(5y)123.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)157.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y-174.07%
EPS Next 2Y-22.81%
EPS Next 3Y22.95%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.59%
Revenue growth 3Y7.26%
Revenue growth 5Y13.76%
Sales Q2Q%0.27%
Revenue Next Year0.59%
Revenue Next 2Y0.65%
Revenue Next 3Y2.54%
Revenue Next 5Y1.05%
EBIT growth 1Y11.55%
EBIT growth 3Y80.05%
EBIT growth 5Y35.21%
EBIT Next Year79.56%
EBIT Next 3Y25.25%
EBIT Next 5Y15.97%
FCF growth 1Y114.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.97%
OCF growth 3Y23.3%
OCF growth 5Y30.88%

MODIV INDUSTRIAL INC / MDV FAQ

Can you provide the ChartMill fundamental rating for MODIV INDUSTRIAL INC?

ChartMill assigns a fundamental rating of 4 / 10 to MDV.


What is the valuation status of MODIV INDUSTRIAL INC (MDV) stock?

ChartMill assigns a valuation rating of 3 / 10 to MODIV INDUSTRIAL INC (MDV). This can be considered as Overvalued.


What is the profitability of MDV stock?

MODIV INDUSTRIAL INC (MDV) has a profitability rating of 5 / 10.


What is the valuation of MODIV INDUSTRIAL INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for MODIV INDUSTRIAL INC (MDV) is 93.25 and the Price/Book (PB) ratio is 0.93.


What is the financial health of MODIV INDUSTRIAL INC (MDV) stock?

The financial health rating of MODIV INDUSTRIAL INC (MDV) is 4 / 10.